05/01
Headlines

Novartis AG

Watch List : Mondelez International, Inc. (NASDAQ:MDLZ), Comcast (NASDAQ:CMCSA), Territorial Bancorp Inc. (NASDAQ:TBNK), Houston Wire & Cable Company (NASDAQ:HWCC), Novartis AG (NYSE:NVS),

Kevin Long03 mins

Mondelez International, Inc. (NASDAQ:MDLZ) appointed Dana Anderson as its new senior vice president and chief marketing officer on Thursday, making her overseer of the company’s global portfolio of advertising, media and marketing partners. Mondelez International, Inc. (NASDAQ:MDLZ) belongs to Consumer Goods sector. Its net profit margin is 10.00% and weekly performance is -2.99%. On last…

Read More

Trader’s Watch List: Facebook Inc (NASDAQ:FB), Novartis (NYSE:NVS), Dolby Laboratories (NYSE:DLB), Ultra Clean Holdings (NASDAQ:UCTT), First Interstate Bancsystem (NASDAQ:FIBK)

Mark DeFrance02 mins

Facebook Inc (NASDAQ:FB) is becoming more than just a social network outlet where people just chat or interact with each other. It’s coming out to be the biggest newsreader platform. Millions of news lovers take news from their social media feeds according to a number of studies. Facebook Inc (NASDAQ:FB) belongs to Technology sector. Its net profit margin is 23.70%…

Read More

Moving Stocks : EMC (NYSE:EMC), Walgreen (NYSE:WAG), Novartis AG (NYSE:NVS), Natural Grocers (NYSE:NGVC), Fresh Del Monte Produce (NYSE:FDP)

Adam Keintzel02 mins

EMC Corporation (NYSE:EMC) today announced that the Company’s Board of Directors has declared a quarterly cash dividend of $0.115 per common share. The dividend will be payable on October 23, 2014 to shareholders of record on October 1, 2014. EMC Corporation (NYSE:EMC)’s stock on 01 August when day-trade ended the stock finally decreased -0.82% to end…

Read More

Hot Movers: Novartis AG (NYSE:NVS), IMAX Corporation (NYSE:IMAX), ImmunoGen (NASDAQ:IMGN), bluebird bio (NASDAQ:BLUE), Randgold Resources (NASDAQ:GOLD)

Jayne Crisman03 mins

Novartis AG (ADR) (NYSE:NVS) announced today the submission of a Biologic License Application (BLA) to the US Food and Drug Administration (FDA) for marketing approval for the use of Bexsero® (Multicomponent Meningococcal Group B Vaccine [recombinant, adsorbed]) to help protect against invasive meningococcal disease caused by serogroup B (meningitis B) in adolescents and young adults…

Read More